Literature DB >> 4010794

Interaction of the neuromuscular blocking drugs alcuronium, decamethonium, gallamine, pancuronium, ritebronium, tercuronium and d-tubocurarine with muscarinic acetylcholine receptors in the heart and ileum.

J Nedoma, N A Dorofeeva, S Tucek, S A Shelkovnikov, A F Danilov.   

Abstract

Neuromuscular blocking drugs have a high affinity for muscarinic acetylcholine receptors in the heart atria and ileal smooth muscle. In experiments on homogenates, alcuronium, gallamine, pancuronium, tercuronium and ritebronium inhibited the binding of the muscarinic antagonist (3H)quinuclidinyl benzilate (QNB) to rat heart atria with IC50 values of 0.15-0.53 mumol X 1(-1) and to ileal longitudinal muscles with IC50 values of 0.12-0.45 mumol X 1(-1). d-Tubocurarine and decamethonium inhibited (3H)QNB binding to these tissues with IC50 values of 6.2-8.5 mumol X 1(-1). For each neuromuscular blocking drug, the IC50 values were virtually identical for (3H)QNB displacement in the homogenates of the atria and of the ileal muscle. Alcuronium and gallamine differed from the other blocking agents in that they produced less steep (3H)QNB displacement curves both in the atria and the ileal muscle; Hill coefficients for the binding of alcuronium and gallamine to atrial and ileal homogenates were lower than unity. On isolated atria, gallamine, pancuronium, ritebronium and tercuronium antagonized the inhibition of tension development caused by the muscarinic agonist, methylfurmethide, with Kd values which were of the same order of magnitude as the IC50 values for the displacement of (3H)QNB binding to homogenates; the Kd of alcuronium was 12.5 times higher. d-Tubocurarine and decamethonium did not antagonize the effects of methylfurmethide at concentrations up to 100 mumol X 1(-1). On isolated ileal longitudinal muscle, gallamine and pancuronium antagonized the effects of methylfurmethide with Kd values that were 53 times and 100 times higher than their respective Kd values in the atria.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4010794     DOI: 10.1007/bf00501209

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  19 in total

1.  [Tercuronium, a new nondepolarizing myorelaxant with high activity and selective action].

Authors:  A F Danilov; V V Malygin; L A Starshinova; N V Khromov-Borisov; S F Torf
Journal:  Farmakol Toksikol       Date:  1979 Sep-Oct

2.  The pharmacology of Flaxedil, with observations on certain analogs.

Authors:  W F RIKER; W C WESCOE
Journal:  Ann N Y Acad Sci       Date:  1951-10       Impact factor: 5.691

3.  Comparison of the autonomic effects of some currently-used neuromuscular blocking agents [proceedings].

Authors:  R J Marshall; J A Ojewole
Journal:  Br J Pharmacol       Date:  1979-05       Impact factor: 8.739

4.  The sympathomimetic effect of gallamine on the heart.

Authors:  B R Brown; J R Crout
Journal:  J Pharmacol Exp Ther       Date:  1970-04       Impact factor: 4.030

5.  Inhibition of the actions of carbachol and DFP on guinea pig isolated atria by alkane-bis-ammonium compounds.

Authors:  H Lüllmann; F K Ohnesorge; G C Schauwecker; O Wassermann
Journal:  Eur J Pharmacol       Date:  1969       Impact factor: 4.432

6.  The ganglion blocking and vagolytic actions of three short-acting neuromuscular blocking drugs in the cat.

Authors:  I G Marshall
Journal:  J Pharm Pharmacol       Date:  1973-07       Impact factor: 3.765

7.  Differential cholinergic sensitivity of sinus and AV nodes.

Authors:  J M Loeb; J M De Tarnowsky; J A Johnsen
Journal:  Eur J Pharmacol       Date:  1982-09-24       Impact factor: 4.432

8.  Competitive interaction of gallamine with multiple muscarinic receptors.

Authors:  J Ellis; W Hoss
Journal:  Biochem Pharmacol       Date:  1982-03-01       Impact factor: 5.858

9.  The interaction of pancuronium with cardiac and ileal muscarinic receptors.

Authors:  E Leung; F Mitchelson
Journal:  Eur J Pharmacol       Date:  1982-05-07       Impact factor: 4.432

10.  Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.

Authors:  J Dunlap; J H Brown
Journal:  Mol Pharmacol       Date:  1983-07       Impact factor: 4.436

View more
  10 in total

Review 1.  Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders.

Authors:  Gregory J Digby; Jana K Shirey; P Jeffrey Conn
Journal:  Mol Biosyst       Date:  2010-06-25

2.  The cardio-selectivity of himbacine: a muscarine receptor antagonist.

Authors:  S Anwar-ul; H Gilani; L B Cobbin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-01       Impact factor: 3.000

3.  Muscarinic receptors mediating suppression of the M-current in guinea-pig olfactory cortex neurones may be of the M2-subtype.

Authors:  A Constanti; J A Sim
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

4.  Pharmacological differences between two muscarinic responses of the rat superior cervical ganglion in vitro.

Authors:  N R Newberry; T Priestley
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

5.  Quest for agonist and antagonist selectivity at muscarinic receptors in guinea-pig smooth muscles and cardiac atria.

Authors:  N A Dorofeeva; S A Shelkovnikov; L A Starshinova; A F Danilov; J Nedoma; S Tucek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000

6.  The interaction of methoctramine and himbacine at atrial, smooth muscle and endothelial muscarinic receptors in vitro.

Authors:  R M Eglen; W W Montgomery; I A Dainty; L K Dubuque; R L Whiting
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

7.  Two populations of muscarinic binding sites in the chick heart distinguished by affinities for ligands and selective inactivation.

Authors:  J Jakubík; S Tucek
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

Review 8.  Allosteric Modulation of Muscarinic Acetylcholine Receptors.

Authors:  Jan Jakubík; Esam E El-Fakahany
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-30

Review 9.  Multitargeting nature of muscarinic orthosteric agonists and antagonists.

Authors:  Jaromir Myslivecek
Journal:  Front Physiol       Date:  2022-09-06       Impact factor: 4.755

10.  Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors.

Authors:  Jan Jakubík; Alena Randáková; Esam E El-Fakahany; Vladimír Dolezal
Journal:  BMC Pharmacol       Date:  2009-12-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.